Pharmacogenomics

Ability of whole-genome SNP arrays to capture `must have' pharmacogenomic variants
pp. 1573-1577(5)
Authors: Peters, Eric J; McLeod, Howard L

Interview
pp. 1583-1584(2)
Author: Daly, Ann K

Research Highlights
pp. 1585-1587(3)
Author: Haufroid, Vincent

BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia
pp. 1589-1593(5)
Author: Rybakowski, Janusz K

Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients
pp. 1595-1603(9)
Authors: Dmitrzak-Weglarz, Monika; Rybakowski, Janusz K; Suwalska, Aleksandra; Skibinska, Maria; Leszczynska-Rodziewicz, Anna; Szczepankiewicz, Aleksandra; Hauser, Joanna

Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype
pp. 1605-1616(12)
Authors: Hayashida, Masakazu; Nagashima, Makoto; Satoh, Yasuo; Katoh, Ryoji; Tagami, Megumi; Ide, Soichiro; Kasai, Shinya; Nishizawa, Daisuke; Ogai, Yasukazu; Hasegawa, Junko; Komatsu, Hiroshi; Sora, Ichiro; Fukuda, Kenichi; Koga, Hisashi; Hanaoka, Kazuo; Ikeda, Kazutaka

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
pp. 1617-1622(6)
Authors: Kaniwa, Nahoko; Saito, Yoshiro; Aihara, Michiko; Matsunaga, Kayoko; Tohkin, Masahiro; Kurose, Kouichi; Sawada, Jun-ichi; Furuya, Hirokazu; Takahashi, Yukitoshi; Muramatsu, Masaaki; Kinoshita, Shigeru; Abe, Masamichi; Ikeda, Hiroko; Kashiwagi, Mariko; Song, Yixuan; Ueta, Mayumi; Sotozono, Chie; Ikezawa, Zenro; Hasegawa, Ryuichi

VKORC1 polymorphisms in Amerindian populations of Brazil
pp. 1623-1629(7)
Authors: Perini, Jamila A; Petzl-Erler, Maria Luiza; Tsuneto, Luiza Tamie; Suarez-Kurtz, Guilherme

VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients
pp. 1631-1638(8)
Authors: Markatos, Christos N; Grouzi, Elissavet; Politou, Marianna; Gialeraki, Argyri; Merkouri, Efrosyni; Panagou, Ioannis; Spiliotopoulou, Ioanna; Travlou, Anthi

Race does not explain genetic heterogeneity in pharmacogenomic pathways
pp. 1639-1645(7)
Authors: Yen-Revollo, Jane L; Auman, J Todd; McLeod, Howard L

Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index
pp. 1647-1656(10)
Authors: Baye, Tes M; Zhang, Yi; Smith, Edward; Hillard, Cecilia J; Gunnell, Jennifer; Myklebust, Joel; James, Roland; Kissebah, Ahmed H; Olivier, Michael; Wilke, Russell A

Malignant hyperthermia: a pharmacogenetic disorder
pp. 1657-1672(16)
Author: Stowell, Kathryn M

Update on the pharmacogenetics of NATs: structural considerations
pp. 1673-1693(21)
Authors: Stanley, Lesley A; Sim, Edith

PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics
pp. 1695-1709(15)
Authors: Zhang, Bin; Xie, Wen; Krasowski, Matthew D

New trends in pharmacogenomic strategies against resistance development in microbial infections
pp. 1711-1723(13)
Authors: Ohlsen, Knut; Dandekar, Gudrun; Schwarz, Roland; Dandekar, Thomas

Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety
pp. 1725-1736(12)
Authors: Kronenberg, Sefi; Frisch, Amos; Rotberg, Beni; Carmel, Miri; Apter, Alan; Weizman, Abraham

CYP2A6 polymorphisms and risk for tobacco-related cancers
pp. 1737-1752(16)
Authors: Rossini, Ana; Simão, Tatiana de Almeida; Albano, Rodolpho Mattos; Pinto, Luis Felipe Ribeiro

Use of diagnostic accuracy as a metric for evaluating laboratory proficiency with microarray assays using mixed-tissue RNA reference samples
pp. 1753-1763(11)
Authors: Pine, PS; Boedigheimer, M; Rosenzweig, BA; Turpaz, Y; He, YD; Delenstarr, G; Ganter, B; Jarnagin, K; Jones, WD; Reid, LH; Thompson, KL

Acknowledgements
pp. 1779-1779(1)